Skip to content
Canine PeptideResearch peptides

Peptides for Beagle intervertebral disc disease (ivdd)

The short answer

Beagles carry an elevated predisposition to intervertebral disc disease (ivdd). The compounds investigated for it are BPC-157, TB-500. At a typical Beagle weight of 9–16 kg (20–35 lb), this breed falls in the medium breed dosing class.

Intervertebral disc disease (IVDD) in Beagles

IVDD occurs when the cushioning disc between vertebrae degenerates and its material displaces into the spinal canal, compressing the cord. In chondrodystrophic breeds — Dachshunds above all — disc degeneration begins in early adulthood, and a herniation can happen during entirely ordinary activity. Presentation ranges from a reluctance to jump to acute paralysis, and severe cases are surgical emergencies where time to decompression drives the outcome. Research interest in peptides here focuses on the recovery period and inflammatory management around the injured cord, always as an adjunct to proper neurological assessment rather than a substitute for it.

Dosing at Beagle body weight

Calculated for a 13 kg (29 lb) dog — the midpoint of the typical range for this breed.

CompoundDose at 13 kgFrequencyEvidence
BPC-15726–130 mcgOnce dailyEmerging evidence
TB-5001.3–3.25 mgWeekly TOTAL — split into 1-2 injections/week for a 2-4 week loading phase, then about half that weekly total for maintenanceEmerging evidence

Weigh your dog rather than using a breed average — an individual Beagle can sit well outside the typical range. Use the dose calculator for an exact figure.

Common questions

What peptides are used for intervertebral disc disease (ivdd) in Beagles?+

BPC-157, TB-500 are investigated for intervertebral disc disease (ivdd). No breed-specific pharmacological restriction is established for Beagles among these compounds.

How much should a Beagle be given?+

Beagles typically weigh 9–16 kg (20–35 lb), placing them in the medium breed class. BPC-157: approximately 26–130 mcg at 13 kg. TB-500: approximately 1.3–3.25 mg at 13 kg. Weigh your dog rather than relying on a breed average.

Are Beagles more prone to intervertebral disc disease (ivdd)?+

Yes. Beagles carry an elevated predisposition to intervertebral disc disease (ivdd). Degeneration and herniation of spinal discs causing pain, weakness, or paralysis — a defining risk in chondrodystrophic breeds.

References

  1. 1.CANINE STUDYHe L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology, 2022. PMID 36588717
  2. 2.CANINE STUDYXu C, Sun L, Ren F, et al. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regulatory Toxicology and Pharmacology, 2020. PMID 32334036
  3. 3.Vasireddi N, Nguyen HH, Ahmed WA, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal, 2025. PMID 40756949
  4. 4.Gwyer D, Wragg NM, Wilson SL Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 2019. PMID 30915550
  5. 5.Józwiak M, Bauer M, Kamysz W, Kleczkowska P Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review. Pharmaceuticals, 2025. PMID 40005999
  6. 6.Mayfield CK, et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. American Journal of Sports Medicine, 2026. PMID 41476424
  7. 7.Kleinman HK, Sosne G Thymosin β4 Promotes Dermal Healing. Vitamins and Hormones, 2016. PMID 27450738
  8. 8.Philp D, Kleinman HK Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Annals of the New York Academy of Sciences, 2010. PMID 20536453
  9. 9.Goldstein AL, Hannappel E, Sosne G, Kleinman HK Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 2012. PMID 22074294
  10. 10.Ho EN, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma. Journal of Chromatography A, 2012. PMID 23084823
  11. 11.Delcourt V, Loup B, Bailly-Chouriberry L, et al. TB500/TB1000 and SGF1000: A scientific approach for a better understanding of misbranded and unapproved drugs. Drug Testing and Analysis, 2023. PMID 36482504

Other conditions Beagles are predisposed to: Osteoarthritis.

Where to source research peptides

Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.

Visit Pet & Peps Research →How to evaluate a supplier

Educational information — not veterinary medical advice

Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.